Photobiostimulation Devices Market Outlook - 2027

Photobiostimulation is a low-level light therapy (LLLT) widely used for minimizing inflammation, edema, and pain. This technique uses LEDs to emit light at different wavelengths such as infrared and red light. With help of this light it helps to heal wounds, nerves and deeper tissues and prevents tissue damage. Photobiostimulation devices emit light that stimulates vascularization and internal heat, ensuing in the faster recovery of wounds. The light from the photobiostimulation device affects a protein in the mitochondria of a cell, stimulates ATP production and reduces oxidative stress. As a result, it minimizing inflammation and improving tissue repair. There are various types of photobiostimulation devices are available in the photobiostimulation devices market such as infrared and red light which is categorized on the basis of wavelength they emit. Out of which the Infrared light photobiostimulation devices gain more popularity as compared to red light due to the various advantages of using such as they have shown positive results for increasing vascularization, increases deep thermal, increase in oxygenation, stimulation of the synthesis of new collagen, and improvement in skin elasticity.

Photobiostimulation devices that emit infrared light are commonly used in some of the pain management clinics and in wound healing. The main objective of manufacturing and develop the market of photobiostimulation devices is to speed up wound healing and reduce the incidences of infection in diabetic foot ulcers, specifically since there is no particular treatment for diabetic foot ulcers. There are various advantages of using photobiostimulation devices includes they are non-invasive in nature and easy to use. Recently this technique is widely used in hair transplantation therapy, where various company provide laser light treatment for hair. The company like “iRestore Laser Corporation” has launched the “iRestore” is a laser used as a hair restoration system intended to treat hereditary hair loss. Photobiostimulation device manufacturers are focusing on developing a mid-600nm red light wavelength, in line with its ability to eliminate 99% contents of a cell within minutes which develop the growth of photobiostimulation device market.

Market scope and structure analysis:

COVID-19 Scenario Analysis:

To take care of infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.

The ongoing outbreak of COVID-19 pandemic impacted the photobiostimulation market. It impacted on the Since the Coronavirus outbreak reached the pandemic status, the entire global supply chain has been impacted, leading the disruption in logistic capabilities and production capacity. Market player and end user losses their business due to the temporarily shutting down of industries in various region. In this situation photobiostimulation associated treatment is stopped.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Globally, North America is considered as a largest market share and dominate overall photobiostimulation devices market. This is attributed to presence of major market player, increasing awareness among the people regarding advanced technology and surgical procedure. However, Asia Pacific is considered as a second largest market share due to low cost of manufacturing photobiostimulation devices, and there are a number of researches being undertaken.

The factors that drive the growth of photobiostimulation device market such as increasing geriatric population, increasing incidence of chronic diseases, growing trend of non-invasive treatment alternatives, availability of low cost of treatment, are driving the growth of the photobiostimulation devices market. However, the factor that restrain the growth of photobiostimulation device market such as presence of fake products available in the market and stringent government for manufacturing of photobiostimulation devices are relatively lenient, therefore the lesser number of quality products available in the market 

New Product launch to flourish the market:

Major Key market manufacturer have been focusing on increasing research and development activities and producing new product solution for specific applications as there are varying demands based on the utilization. Leading market players have determined how improved accuracy can be influential in many applications. In 2018, “Erchonia Corporation” has received U.S.FDA approval for the “FX 635 Laser” for treating chronic low back pain of musculoskeletal origin. The FX 635 Laser is the only FDA-approved laser in the market for chronic neck and shoulder pain treatment. In 2018, “iRestore Laser Corporation” has launched the “iRestore” is a laser used as a hair restoration system intended to treat androgenic alopecia means “hereditary hair loss”. In 2018, “Erchonia Corporation”, entered into a collaboration with “InnerScope Hearing Technologies”, and launched the “Erchonia 3LT lasers” which is used for the treatment of hearing disorders. 

Key segments covered:

Key benefits of the report:

• This study presents the analytical depiction of the global photobiostimulation devices market along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global photobiostimulation devices market share.
• The current market is quantitatively analyzed from 2020 to 2027 to highlight the global photobiostimulation devices market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
• The report provides a detailed global photobiostimulation devices market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Photobiostimulation Devices Market research report:

• Who are the leading market players active in photobiostimulation devices market?
• What are the current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that will help in taking further strategic steps?

 Key Market Segments

 
Key Market Players

• THOR Photomedicine Ltd,
• Bioflex Laser Therapy
• Ingeneus Pty. Ltd.
• iRestore Laser
• LumiWave
• Biolight Technologies
• Omega Laser Systems
• TheraDome Inc.
• Vielight Inc.
• iGrow Laser